ArticleBMC health services research2024
Early age at menarche and history of sexually transmitted infections significantly predict cervical cancer screening uptake among women aged 25-49 years: evidence from the 2021 Côte d'Ivoire demographic and health survey.
Article in BMC health services research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 10 citations in OpenAlex.
- Effect of Mindfulness-Based Social-Emotional Learning Approach on Knowledge and Anxiety Levels Regarding Cervical Cancer Prevention.Healthcare (Basel, Switzerland) · 2026Article
- Cervical Cancer Screening Prevalence and Predictors Among Women Aged 25-49 Years in Ghana: A Cross-Sectional Study.Health science reports · 2026Article
- Understanding Cervical Cancer Screening Intentions Through the Lens of Care-Seeking Behavior: A Cross-Sectional Study Among Islamic Women in Ghana.Health science reports · 2026Article
- Factors and pathways Influencing Fertility Anxiety in Reproductive-Age Male Cancer Patients: A Stress Process Theory Perspective.Reproduction & fertility · 2026Article
- Menstrual, reproductive, and contraceptive factors associated with cervical cancer in women aged ≤35 years: an individually matched case-control study.Frontiers in oncology · 2026Article
- Prevalence, risk factors, and perceptions of vaccination against reproductive tract infections among urban females in Delhi: a cross-sectional study.Frontiers in reproductive health · 2026Article
- Association between mass media exposure and cervical cancer screening uptake among women aged 30-49 years in four sub-Saharan African countries: a pooled analysis of demographic and health surveys.BMC women's health · 2025Article
- Assessing the socioeconomic inequalities in cervical cancer screening in sub-Saharan Africa: a decomposition analysis.International journal for equity in health · 2025Article
- Factors Influencing Cervical Cancer Screening: A Cross-Sectional Study Among Ethnically Diverse Women in the Kumasi Metropolis of Ghana.Health science reports · 2025Article
- Construction of a Nomogram Prediction Model for Individualized Prediction of Cervical Cancer Risk: A Retrospective Study.International journal of women's health · 2025Article
- Factors influencing clinical breast cancer screening: A cross-sectional study among Islamic women in Kumasi Metropolis of Ghana.PloS one · 2025Article
- Factors associated with age at first screening for cervical cancer among adult Cape Verdean women: a cross-sectional study.BMC public health · 2024Article
- Knowledge, attitudes, and practices regarding cervical cancer screening among women in Damascus, Syria: A cross-sectional study.Women's health (London, England)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer is the second dominant type of cancer among Ivorian women with an estimated age-standardised incidence and mortality rate of 31.2 cases and 22.8 deaths per 100,000 women in 2020, respectively. The Ivorian government through its Ministry of Health implemented the National Cancer Control Programme (NCCP) in 2003 with the aim of improving the prevention, early detection and treatment of cancers in Côte d'Ivoire. Yet, there is a low uptake of CCS (1.2%). Thus, making CCS uptake an important public health concern in the country. Understanding of the extent to which reproductive factors predict CCS uptake is limited in literature. This study aimed to investigate reproductive factors as a predictor of women's uptake of CCS in Côte d'Ivoire.
methodsData from the 2021 Côte d'Ivoire Demographic and Health Survey. A sample of 9,078 women aged 25-49 years were analyzed. The outcome variable was CCS uptake while other variables considered included age at menarche, history of STI, sexual debut, parity, age, educational level, wealth index, health insurance, place of residence, and media exposure. A multivariable logistic regression model was fitted to examine the association between the outcome of interest and predictors at 95% confidence interval.
resultsApproximately, 7.52% of women aged 25-49 years had ever undergone testing for cervical cancer by a healthcare provider. Early menarche was associated with lower odds of CCS uptake [AOR = 0.78; CI = 0.65-0.95]. Compared to those who had no STI, women with a history of STI were more likely to screen for cervical cancer [AOR = 2.63; CI = 2.02-3.42]. Increasing age, higher educational attainment, having health insurance, and being exposed to media were significantly associated with CCS uptake.
conclusionIn Cote d'Ivoire, age at menarche and STI history constitute reproductive factors that were significantly associated with women's uptake of CCS. It is imperative for public policy to focus on increasing CCS in these higher-risk women (i.e., women who experienced early menarche, women with early sexual debut and higher parity) through increased sensitization on cervical cancer risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.